What is Centerline Biomedical worth?
$67.2Mlast known valuation
Centerline Biomedical last raised $10.8M in its Early Stage VC (Apr 2025).
Free account
See the evidence behind this price
- ·Post-money valuations for all 4 rounds
- ·The complete investor list — 15 names
- ·Watchlist + deal alerts for Centerline Biomedical
Create free account
No card required
Funding history
4 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Apr 2025 | Early Stage VC | $10.8M | ▮ | ▮ |
| Feb 2022 | Early Stage VC | $34.7M | ▮ | ▮ |
| Aug 2019 | Early Stage VC | $12.7M | ▮ | ▮ |
| Aug 2015 | Early Stage VC | $13.7M | ▮ | ▮ |
How Centerline Biomedical's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Centerline Biomedical, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked
- What is Centerline Biomedical worth?
- Centerline Biomedical's last known valuation is $67.2M.
- How much has Centerline Biomedical raised?
- Centerline Biomedical has raised $79.4M in total funding across 4 recorded rounds.
- When did Centerline Biomedical last raise?
- Centerline Biomedical last raised in Apr 2025 (Early Stage VC), raising $10.8M.